The mechanisms of the improvement of insulin sensitivity by angiotensin converting enzyme inhibitor

Clinical and Experimental Hypertension

Volumn 18, Issue 2, 1996, Pages 257-266

  Shimamoto, K ^a   Ura, N ^a   Nakagawa, M ^a   Higashiura, K ^a   Takizawa, H ^a   Miyazaki, Y ^a   Nomura, N ^a   Hirata, A ^a   Takagawa, Y ^a   Murakami, H ^a   Iimura, O ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

angiotensin converting enzyme inhibitor; bradykinin receptor antagonist; fructose fed rats; insulin sensitivity

Indexed keywords

BRADYKININ RECEPTOR; DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRUCTOSE; GLUCOSE; ICATIBANT; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; DRUG MECHANISM; HYPERTENSION; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9244251602     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609081768     Document Type: Article

References (26)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
2. Kaplan NM: The deadly quartet. Upperbody obesity, glucose intolerance in hypertriglycemia and hypertension. Arch Intern Med 1989;149:1514-1520
3. DeFronzo RA, Ferrannini E: Insulin resistance - A multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194
4. Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H: Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 1991;84:1165-1175
5. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, oleggini M, graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 1987;316:350-357
6. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321:868-873
7. Rett K, Lotz N, Wicklmayr M, Fink E, Jauch KW, Gunther B, Dietze G: Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ-II-Diabetiker. Dtsch Med Wochenschr 1988;113:243-249
8. Paolisso G, Gambardella A, Verza M, D'Amre A, Sgambato S, Varricchio M: ACE inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 1992;6:175-179
9. Tomiyama H, Kushiro T, Abeta H, Ishii T, Takahashi A, Furukawa L., Asagami T, Hino T, Saito F, Otsuka Y, Kurumatani H, Kobayashi F, Kanmatsuse K, Kajiwara N: Kanins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 1994;23:450-455
10. Zavaroni I, Sanders S, Scott S, Reaven GM: Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980;29:970-973
11. Tobey TA, Mondon CE, Zavaroni I, Reaven GM: Mechanism of insulin resistance in fructose-fed rats. Metabolism 1982;31:608-612
12. Reaven EP, Wright DW, Mondon CE, Solomon R, Ho H, Reaven GM: Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 1983;32:175-180
13. Reaven GM, Ho H, Hoffman BB: Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988;12:129-132
14. Lucas CP, Estigarribia JA, Darga LL, Reaven GM: Insulin and blood pressure in obesity. Hypertension 1985;7:702-706
15. Modan M, Halkin H, Almog S, Lusky A, Eskol A, Shefi M, shitrit A, Fuchs I: A link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75:809-817
16. Singer P, Godicke W, Voit S, Haj I, Weiss M: Postprandial hyperinsulinemia in patients with mild hypertension. Hypertension 1985;7:182-186
17. Shimamoto K, Nakagawa M, Higashiura K, Miyazaki Y, Shiiki M, Masuda A, Iimura O: Insulin sensitivity and renal sodium-water metabolism in obese normotensive subjects. Ann NY Acad Sci 1993;676:345-349
18. Shimamoto K, Hirata A, Fukuoka M, Higashiura K, Miyazaki Y, Shiiki M, Masuda A, Nakagawa M, Iimura O: Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients. Hypertension 1994;23(Suppl I):I-29-I-33
19. Shimamoto K, Matsuda K, Takizawa H, Higashiura K, Ura N, Iimura O: Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats. Blood Pressure 1994;3(Suppl 5): 113-116
20. Iimura O, Shimamoto K, Matsuda K, Masuda A, Takizawa H, Higashiura K, Miyazaki Y, Hirata A, Ura N, Nakagawa M: Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 1995;8:353-357
21. Moan A, Risanger T, Eide I, Kjeldsen SE: The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. Blood Pressure 1994;3:185-188
22. Townsend RR, DiPette DJ: Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol 1993;265:E362-E366
23. Buchanan TA, Thawani H, Kades W, Modrall JG, Weaver FA, Laurel C, Poppiti R, Xiang A, Hsueh W: Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 1993;92:720-726
24. Iimura O, Shimamoto K, Tanaka S, Hosoda S, Nishimiya T, Ando T, Masuda A: The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems. Jpn J Med 1986;25:34-39
25. Tanaka S, Shimamoto K, Ando T, Nakahashi Y, Ura, N, Hosoda S, Ishida H, Yamaji I, Yokoyama T, Masuda A, Iimura O: Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effect of converting enzyme inhibitor, Alacepril. Clin Exp Hypertens 1987A9:605-609
26. Bao G, Gohlke P, Qadri F, Unger T: Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 1992;20:74-79